Physician profile
Anna P Tran
NPI 1962523613
$4,081.25
in general payments reported to CMS, 2019-2025
32 companies · $67.37 in 2025
The $67.37 reported for 2025 was more than what a typical Occupational Medicine provider received nationally (typical 2025 total: $53.66).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $493 · 2021: $1,216 · 2022: $599 · 2023: $741 · 2024: $702 · 2025: $67.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $653.79 | 2019-2024 | Vraylar, Ubrelvy, Linzess |
| Astrazeneca Pharmaceuticals LP | $511.26 | 2019-2024 | Breztri, Farxiga, Airsupra |
| Abbott Laboratories | $494.36 | 2019-2025 | Proclaim |
| Amgen INC. | $357.72 | 2019-2024 | Otezla, Repatha |
| Lilly USA, LLC | $335.68 | 2019-2024 | Mounjaro, Jardiance |
| Pfizer INC. | $220.49 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.74 | 2020-2024 | Jardiance, Tradjenta |
| Gilead Sciences, INC. | $168.32 | 2019-2024 | |
| Nestle Healthcare Nutrition INC. | $134.36 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $101.16 | 2019-2023 | |
| Boston Scientific Corporation | $91.60 | 2021-2025 | Watchman Access System, General - Pain Management |
| Astellas Pharma US INC | $75.36 | 2024 | Veozah |
| Lucid Diagnostics INC. | $72.82 | 2021-2023 | |
| Glaxosmithkline, LLC. | $70.74 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $67.61 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicure Pharma INC. | $67.09 | 2020 | |
| Allergan, INC. | $63.51 | 2019-2021 | |
| Amarin Pharma, INC. | $44.27 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.79 | 2022-2024 | |
| Aimmune Therapeutics, INC. | $35.82 | 2024 | |
| Hologic Sales and Service, LLC | $33.96 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $33.77 | 2021 | |
| Sumitomo Pharma America, INC. | $31.71 | 2024 | Gemtesa |
| Nevro Corp. | $28.49 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.74 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.03 | 2021 | |
| Abiomed | $19.49 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $17.33 | 2019 | |
| Intuitive Surgical, INC. | $15.91 | 2021 | |
| Medtronic Vascular, INC. | $15.25 | 2020 | |
| Alkermes, INC. | $15.17 | 2023 | Aristada, Lybalvi |
| Phadia US INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.